jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 31, 2020

Dec. 20, 2021

jRCT2080225296

-

-

Eli Lilly Japan K.K.

-

+81-120-023-812

-

Eli Lilly Japan K.K.

-

+81-120-023-812

-

recruiting

Sept. 01, 2020

280

Interventional

-

treatment purpose

2

-

-

18age old over
65age old under

Both

-

investigational material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code : 399 Agents affecting metabolism, n.e.c.
Dosage and Administration for Investigational material : -

control material(s)
Generic name etc : -
INN of investigational material : -
Therapeutic category code : --- Other
Dosage and Administration for Investigational material : -

efficacy
-

efficacy
pharmacokinetics
-

Eli Lilly Japan K.K.
-
-
-
-
-

-

approved

July. 06, 2020

NCT04433585
ClinicalTrials.gov
JapicCTI-205392
Japan/Asia except Japan/North America/South America/Europe/Oceania/-

History of Changes

No Publication date
3 Dec. 20, 2021 (this page) Changes
2 Nov. 18, 2020 Detail Changes
1 Aug. 03, 2020 Detail